Useful Information
Please contact us for any questions or request for reagents.
Materials and Methods: TULP1 (3C5N)
| Structure | TULP1 |
|---|---|
| PDB Code | 3C5N |
| Entry clone accession | BC032714 |
| Entry clone source | Mammalian Gene Collection |
| Tag | N-terminal hexahistidine tag with integrated TEV protease cleavage site: mhhhhhhssgvdlgtenlyfq*sm |
| Construct sequence | mhhhhhhssgvdlgtenlyfq*smEPREFVLRPAPQGRTVRCRLTRDKKGMDRGMYPSYFLHLDTEKKVFLLAGRKRKRSKTANYLISIDPTNLSRGGENFIGKLRSNLLGNRFTVFDNGQNPQRGY STNVASLRQELAAVIYETNVLGFRGPRRMTVIIPGMSAENERVPIRPRNASDGLLVRWQNKTLESLIELHNKPPVWNDDSGSYTLNFQGRVTQASVKNFQIVHADDPDYIVLQFGRVAEDAFTLDYR YPLCALQAFAIALSSFDG |
| Vector | pNIC-Bsa4 |
| Expression host | E.coli BL21(DE3) (Novagen) |
| Growth method | Cells from a glycerol stock were grown in 50 mL LB supplemented with 50 µg/mL kanamycin at 30 ºC overnight. The overnight culture (15 mL) was used to inoculate 2 x 750 mL TB supplemented with 8 g/l glycerol, 50 µg/mL kanamycin and approximately 50 µl BREOX FMT 30 anti-foam solution (Cognis Performance Chemicals UK Ltd). The cultures were grown in TunAir flasks at 37 ºC until OD600 reached ~1.1. The flasks were down-tempered to 18 ºC over a period of 1 hour before target expression was induced by addition of 0.5 mM IPTG. Expression was allowed to continue overnight and cells were harvested the following morning by centrifugation (4,400 x g, 10 min, 4 ºC). The resulting cell pellet (38.3 g wet cell weight) was resuspended in lysis buffer (1 mL/g cell pellet), supplemented with two tablets of Complete EDTA-free protease inhibitor (Roche Applied Science) and a knife edge of lysozyme (Sigma). The cell suspension was stored at -80 ºC. |
| Extraction buffers | Lysis buffer: 50 mM HEPES, 500 mM NaCl, 10% glycerol, 10 mM imidazole, 0.5 mM TCEP, pH 8.0. |
| Extraction procedure | The cell suspension was quickly thawed in water and 2000 U Benzonase was added. Cells were disrupted by high-pressure homogenization (TC5-0612W-332, Stansted fluid power LTD) and cell debris was removed by centrifugation (49,100 x g, 20 min, 4 ºC). The supernatant was decanted and filtered through a 0.45 µm flask filter. |
| Purification buffers | IMAC wash1 buffer: 50 mM HEPES, 500 mM NaCl, 10% glycerol, 10 mM imidazole, 0.5 mM TCEP, pH 7.5 IMAC wash2 buffer: 50 mM HEPES, 500 mM NaCl, 10% glycerol, 25 mM imidazole, 0.5 mM TCEP, pH 7.5 IMAC elution buffer: 50 mM HEPES, 500 mM NaCl, 10% glycerol, 500 mM imidazole, 0.5 mM TCEP, pH 7.5 Gel filtration (GF) buffer: 20 mM HEPES, 300 mM NaCl, 10% glycerol, 0.5 mM TCEP, pH 7.5 |
| Purification procedure | Columns Procedure |
| Crystallization | Crystals were obtained by the sitting drop vapour diffusion method in a 96-well plate. 1 µl protein solution (diluted to 20 mg/mL) including 1 mM myo-inositol 1,4,5 P3 was mixed with 0.5 µl well solution consisting of 10% (w/v) PEG 8000 and 10% (w/v) PEG 1000. The plate was incubated at 20 ºC and crystals appeared within 12 days. The crystals were quickly transferred to a cryo solution consisting of well solution complemented with 15% 2,3-butanediol and 5 mM myo-inositol 1,4,5 P3, and flash frozen in liquid nitrogen. |
| Data collection | Data was collected at BESSY beamline 14.2. |
| Data processing | The data was integrated and scaled with XDS and XSCALE. The 1.8 Å structure was solved using 2FIM as the starting model in space group P21 and unit cell a=56.3, b=83.6, c=57.7, α9=0.00, β=94.01, γ=90.00. The model was refined using PHENIX and manually built using Coot. Residuals were Rfactor 0.189 and Rfree 0.221. |


